|
|
 |
|
Viewing report
|
|
|
|
Market Analysis of Cardiac Rhythm Management (CRM) Devices in Selected Asian Countries - Executive Summary
Frost & Sullivan, June 2006, Pages: 17
This Frost & Sullivan research service titled Market Analysis of Cardiac Rhythm Management (CRM) Devices in Selected Asian Countries provides drivers and restraints from 2005 to 2012 and the market size and revenue estimates between 2002 and 2012.
In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets/applications/technologies: implantable pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and CRM leads in regions such as China, Hong Kong, South Korea, and Malaysia.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Healthcare
- Medical devices
- Cardiovascular devices
- Cardiac rhythm management devices
Technologies
The following technologies are covered in this research:
- Implantable pacemakers
- Implantable cardioverter defibrillators (ICDs)
- Cardiac resynchronization therapy (CRT) or biventricular pacing
- CRM leads and electrodes
Market Overview
Aging Population Creates Wider Customer Base for Cardiac Rhythm Management Devices in Asia
Congestive heart failures (CHF) and heart arrhythmias are increasingly becoming common ailments among Asians, especially since the ageing population segment (65 years and above) is particularly susceptible to these diseases. With more than 10 percent of Asia’s population expected to fall under this age bracket by 2010, there will be considerable rise in demand for cardiac rhythm management (CRM) devices, says the analyst of this research. A significant number of patients implanted with pacemakers have associated diseases - nearly 25 percent has hypertension and 15 percent has ischaemic heart diseases, creating a greater market for CRM tools.
Studies from the U. S. National Heart, Lung & Blood Institute have also indicated that obesity and unhealthy lifestyle can cause higher incidence of cardiac disorders. While the greater prevalence of CHF and heart arrhythmias will create immense demand for CRM devices, participants should take into account the lower household income of patients from Asia and price their products competitively, apart from ingeniously distributing the right mix of products.
Healthy Asian Economy Encourages Investments in CRM Market
The emerging markets for CRM devices in Asia are expected to receive a huge boost with greater coverage by medical insurance and governments allocating higher budgets for healthcare. The governments are promoting the construction of sophisticated medical facilities, in line with a steadily growing economy. This stability encourages the development of more numbers of tertiary-level medical facilities to serve more patients. With an increasingly urban population, larger numbers of patients are expected to gain access to CRM devices, notes the analyst. A sizeable urban population base totaling nearly 2.5 billion will go a long way in supporting market growth.
Apart from governments promoting the healthcare industry, private investors are also evincing interest in offering superior services. This ensures the availability of better-trained medical professionals, which in turn, will increase confidence among both patients and medical professionals. The customer base can be expanded with greater ease by improving the levels of patient education.
Please note this is an executive summary only. Full reports are available on each individual country - please search our website for further details.
Also available
Market Analysis of Cardiac Rhythm Management (CRM) Devices in China
Market Analysis of Cardiac Rhythm Management (CRM) Devices in Hong Kong
Market Analysis of Cardiac Rhythm Management (CRM) Devices in South Korea
Market Analysis of Cardiac Rhythm Management (CRM) Devices in Malaysia
|
|
|
|
